ONCOMATRYX

Pioneering Tumor Quantum Immunotherapy

Derio, Spain · Founded 2010 · $111.6M raised

Headquarters
Derio
Employees
11–50
Founded
2010
Business Model
B2B
Total Funding
$111.6M
Last Round
$67.0M Venture RoundMar 2026
Rounds
4

About

ONCOMATRYX is a clinical-stage biopharmaceutical company pioneering Tumor Quantum Immunotherapy by developing antibody-drug conjugates (ADCs) that target the tumor microenvironment. Their lead candidate, OMTX705, has received FDA and AEMPS IND clearance for treating advanced solid tumors by targeting Fibroblast Activation Protein. The company uses AI and quantum computing to assist in ADC design and candidate selection. Based in Derio, Bizkaia, Spain, ONCOMATRYX has raised $67 million to advance its clinical pipeline.

Summary

ONCOMATRYX is a Biotech company based in Derio, Spain, founded in 2010. It has raised $111.6M in total across 4 rounds, most recently a $67.0M Venture Round round in Mar 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding RoundMar 2026
$67.0M

Sign up to see all 4 rounds

Series C through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ONCOMATRYX on Indexed.vc
<a href="https://indexed.vc/companies/oncomatryx"><img src="https://indexed.vc/api/badge/company/oncomatryx" alt="ONCOMATRYX on Indexed.vc" width="260" height="76" /></a>